Deccan Health Care Ltd
NSE: BSE: 542248
₹6.85
(-6.42%)
Mon, 06 Apr 2026, 06:12 pm
Market Cap160.46M
PE Ratio7.39
Dividend0
Health Technology
Pharmaceuticals: Other
24.5KDeccan Health Care Financials
| Particulars | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 94.08M | 70.41M | 91.49M | 172.22M | 294.00M | 378.27M | 442.48M | 422.44M | 337.76M | 331.71M | 450.22M | 597.29M | 750.58M |
| Gross profit | 8.21M | 7.97M | 30.31M | 94.96M | 162.04M | 201.02M | 233.95M | 185.43M | 96.56M | 131.95M | 131.17M | 143.46M | 167.43M |
| Operating expenses (excl. COGS) | -56.31M | -46.06M | -23.58M | -27.62M | -46.42M | -73.29M | -78.10M | -82.85M | -90.84M | -90.38M | -125.79M | -114.86M | -150.44M |
| Selling/general/admin expenses, total | -56.31M | -46.06M | -23.58M | -27.73M | -46.42M | -70.26M | -74.63M | -82.85M | -81.28M | -90.38M | -125.24M | -114.78M | -150.10M |
| Research & development | — | — | — | — | — | -2.28M | -603.00K | -5.71M | -473.00K | -127.00K | -134.00K | 0 | 0 |
| Selling/general/admin expenses, other | -56.31M | -46.06M | -23.58M | -27.73M | -46.42M | -67.98M | -74.03M | -77.14M | -80.81M | -90.25M | -125.24M | -114.78M | -150.10M |
| Other operating expenses, total | 0 | 0 | 0 | 107.00K | 0 | -3.03M | -3.47M | 0 | -9.56M | 0 | -557.00K | -83.00K | -342.00K |
| Operating income | -48.09M | -38.09M | 6.73M | 67.33M | 115.63M | 127.73M | 155.85M | 102.58M | 5.72M | 41.57M | 5.37M | 28.60M | 16.99M |
| Non-operating income, total | -14.65M | -14.90M | -17.07M | -16.59M | -20.95M | 5.72M | -10.19M | -1.26M | -525.00K | -36.15M | -977.00K | -6.46M | -685.00K |
| Interest expense, net of interest capitalized | -14.81M | -14.95M | -15.16M | -14.78M | -21.43M | -14.98M | -10.36M | -1.83M | -1.08M | -1.52M | -1.17M | -862.00K | -742.00K |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 164.00K | 54.00K | 478.00K | 72.00K | 481.00K | 20.69M | 840.00K | 572.00K | 554.00K | -628.00K | 194.00K | -5.60M | 57.00K |
| Non-operating interest income | 19.00K | 54.00K | 12.00K | 13.00K | 116.00K | 98.00K | 50.00K | 136.00K | 76.00K | 39.00K | 84.00K | 112.00K | 5.00K |
| Miscellaneous non-operating expense | 145.00K | 0 | 466.00K | 59.00K | 365.00K | 20.59M | 790.00K | 436.00K | 478.00K | -667.00K | 110.00K | -5.71M | 52.00K |
| Unusual income/expense | — | — | -2.39M | -1.89M | — | 0 | -671.00K | 0 | 0 | -34.00M | 0 | 0 | 0 |
| Pretax income | -62.74M | -52.99M | -10.34M | 50.74M | 94.67M | 133.45M | 145.67M | 101.32M | 5.19M | 5.42M | 4.40M | 22.14M | 16.30M |
| Taxes | -2.09M | -1.32M | -537.00K | -73.00K | 203.00K | 150.00K | -863.00K | -444.00K | -1.29M | -2.20M | -1.34M | -7.21M | -4.71M |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | -64.83M | -54.31M | -10.88M | 50.66M | 94.88M | 133.60M | 144.81M | 100.87M | 3.90M | 3.23M | 3.06M | 14.93M | 11.59M |
| Net income | -64.83M | -54.31M | -10.88M | 50.66M | 94.88M | 133.60M | 144.81M | 100.87M | 3.90M | 3.23M | 3.06M | 14.93M | 11.59M |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | -64.83M | -54.31M | -10.88M | 50.66M | 94.88M | 133.60M | 144.81M | 100.87M | 3.90M | 3.23M | 3.06M | 14.93M | 11.59M |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | -36.63M | -26.59M | 18.24M | 78.84M | 127.53M | 140.54M | 168.72M | 116.75M | 20.38M | 56.30M | 19.65M | 43.26M | 31.51M |
| EBIT | -48.09M | -38.09M | 6.73M | 67.33M | 115.63M | 127.73M | 155.85M | 102.58M | 5.72M | 41.57M | 5.37M | 28.60M | 16.99M |
| Total operating expenses | -142.17M | -108.50M | -84.76M | -104.88M | -178.38M | -250.54M | -286.62M | -319.86M | -332.04M | -290.14M | -444.84M | -568.69M | -733.59M |
| Prepaid expenses | — | — | — | 92.00K | — | 9.50M | 601.00K | 360.00K | 224.00K | 146.00K | 63.00K | 197.00K | 163.00K |
| Deferred income, current | — | — | — | — | 18.93M | 14.07M | 9.30M | 1.85M | 2.89M | 2.84M | 3.78M | 4.05M | 25.62M |
| Capital and operating lease obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 15.28M | 16.61M | 17.14M | 17.22M | 17.02M | 20.06M | 20.92M | 21.37M | 21.27M | 20.95M | 19.86M | 18.51M | 17.01M |
| Deferred income, non-current | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in accrued expenses | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800